This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Intercytex Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Mike Leek - Innovator in Tissue Repair Technology
Introduction
Mike Leek is a notable inventor based in Manchester, GB. He has made significant contributions to the field of tissue repair, particularly through his innovative methods involving allogeneic dermal fibroblasts. His work aims to enhance the quality of life for individuals requiring cosmetic and medical tissue augmentation.
Latest Patents
Mike Leek holds a patent for a method of tissue repair using allogeneic dermal fibroblasts. This invention provides a method for the repair of subcutaneous or dermal tissue in a subject. The process involves injecting a suspension of allogeneic dermal fibroblasts into the subject, which allows for long-term augmentation of the subadjacent tissue. This method offers advantages over traditional materials, such as autologous fibroblast cells or collagen, by minimizing the associated disadvantages.
Career Highlights
Throughout his career, Mike has focused on developing innovative solutions in the field of tissue repair. His work has led to advancements that improve the efficacy and safety of cosmetic procedures. He is currently associated with Intercytex Limited, where he continues to push the boundaries of tissue engineering.
Collaborations
Mike Leek has collaborated with various professionals in the field, including his coworker Paul Kemp. Their combined expertise has contributed to the development of groundbreaking techniques in tissue repair.
Conclusion
Mike Leek's contributions to the field of tissue repair through his innovative patent demonstrate his commitment to advancing medical technology. His work not only enhances cosmetic procedures but also improves patient outcomes in tissue augmentation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile